Home   >  
∨

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

Hormone Pathay

Chemical Structure Cat. No. Product Name CAS No.
GPR81 agonist 1 Chemical Structure
 BCP36389 GPR81 agonist 1 1620992-67-7
GPR81 agonist 1 is a potent and highly selective GPR81 agonist, with EC50s of 58 nM and 50 nM for human and mouse GPR81, respectively.
Masofaniten Chemical Structure
 BCP49523 Masofaniten 2416716-62-4
Masofaniten is an antiandrogen and an antineoplastic.
LPCN-1144 Chemical Structure
 BCP49389 LPCN-1144 LPCN-1144
LPCN 1144 is an oral prodrug of bioidentical testosterone that is absorbed through intestinal lymphatics and intended for the treatment of hypogonadism in males.
AC-0176 Chemical Structure
 BCP49348 AC-0176 AC-0176
AC176 is an investigational medicinal product that is a potent orally bioavailable Androgen Receptor (AR) degrader.
OP-1250 Chemical Structure
 BCP49307 OP-1250 OP-1250
OP-1250 is a novel oral compound developed to completely antagonize the estrogen receptor (ER) and block the ER-mediated cancer cell growth and proliferation signal.
Onapristone Chemical Structure
 BCP49272 Onapristone 96346-61-1
Onapristone is a progesterone receptor antagonist potentially for the treatment of breast cancer, advanced prostate cancer, and inducer of vaginal bleeding.
L(-)-Epinephrine Chemical Structure
 BCP09042 L(-)-Epinephrine 51-43-4
L-Epinephrine is a hormone secreted by the medulla of the adrenal glands. L-Epinephrine is an α-adrenergic and β-adrenergic receptor agonist.
Nalbuphine Chemical Structure
 BCP49246 Nalbuphine 20594-83-6
Nalbuphine is a narcotic used as a pain medication. It appears to be an agonist at kappa opioid receptors and an antagonist or partial agonist at mu opioid receptors.
Nalbuphine hydrochloride Chemical Structure
 BCP49247 Nalbuphine hydrochloride 23277-43-2
Nalbuphine Hydrochloride is the hydrochloride salt form of nalbuphine, a synthetic phenanthrene opioid with opiate agonist and antagonist effects, used to treat moderate to severe pain and provide preoperative and postoperative analgesia and sedation.
TERN-501 Chemical Structure
 BCP49228 TERN-501 TERN-501
TERN 501 is an orally administered, small molecule therapeutic, being developed as a thyroid hormone receptor beta (THR-β) agonist, for the treatment of.
123下一页末页共 387 条记录 1 / 39 页 
0086-13720134139